Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 71.98%
March 31, 2026 72.20%
December 31, 2025 73.37%
September 30, 2025 80.89%
June 30, 2025 71.29%
March 31, 2025 62.39%
December 31, 2024 64.65%
September 30, 2024 77.31%
June 30, 2024 79.20%
March 31, 2024 78.90%
December 31, 2023 79.62%
September 30, 2023 79.24%
June 30, 2023 76.62%
March 31, 2023 78.29%
December 31, 2022 77.74%
September 30, 2022 79.51%
June 30, 2022 78.76%
March 31, 2022 77.95%
December 31, 2021 76.25%
September 30, 2021 77.63%
June 30, 2021 78.89%
March 31, 2021 77.12%
December 31, 2020 74.57%
September 30, 2020 74.07%
June 30, 2020 72.26%
Date Value
March 31, 2020 70.37%
December 31, 2019 74.13%
September 30, 2019 74.38%
June 30, 2019 75.38%
March 31, 2019 74.21%
December 31, 2018 73.73%
September 30, 2018 75.10%
June 30, 2018 74.40%
March 31, 2018 71.72%
December 31, 2017 69.93%
September 30, 2017 71.78%
June 30, 2017 70.54%
March 31, 2017 71.63%
December 31, 2016 71.72%
September 30, 2016 74.17%
June 30, 2016 69.73%
March 31, 2016 67.43%
December 31, 2015 70.30%
September 30, 2015 68.26%
June 30, 2015 66.25%
March 31, 2015 69.46%
December 31, 2014 56.65%
September 30, 2014 65.26%
June 30, 2014 68.17%
March 31, 2014 68.81%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 67.76%
Enovis Corp. 54.51%
Stryker Corp. 66.14%
Zimmer Biomet Holdings, Inc. 62.91%
Edwards Lifesciences Corp. 78.09%